On April 2, 2020, Xu, Jianyan; Zhang, Ying; Cai, Xiaofeng; Qu, Bolei; Liang, Jindong; Zhang, Lianshan; He, Feng; Tao, Weikang published a patent.Recommanded Product: 3-Cyclopropyl-2-hydroxypropanoic acid The title of the patent was Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof. And the patent contained the following:
The present invention relates to a ligand-drug conjugate of an exatecan analog, a preparation method therefor and an application thereof. Specifically, the present invention provides a ligand-drug conjugate having a structure shown in formula (-D), a preparation method therefor, a pharmaceutical composition containing same, and use thereof in preparation of drugs for treating cancers by means of receptor regulation. The definition of each substituent in formula (-D) is the same as that in the description. The experimental process involved the reaction of 3-Cyclopropyl-2-hydroxypropanoic acid(cas: 1599840-16-0).Recommanded Product: 3-Cyclopropyl-2-hydroxypropanoic acid
The Article related to ligand drug conjugate exatecan analog, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: 3-Cyclopropyl-2-hydroxypropanoic acid
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts